Actively Recruiting
Natural History of Wilson Disease: Registry for Patients With Wilson Disease
Led by Yale University · Updated on 2025-05-22
300
Participants Needed
6
Research Sites
N/A
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
W
Wilson Disease Association
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to understand Wilson disease by following a group of patients over time at specialized centers in the United States and the United Kingdom. The study focuses on the natural course of Wilson disease and evaluates ways to improve diagnosis and treatment monitoring, especially for patients receiving chelation therapy or zinc treatment. Researchers also plan to explore new markers that could help track treatment progress in future clinical trials. Participants diagnosed with Wilson disease will be observed as part of a registry that collects data and specimens. This study does not involve any active treatment but focuses on gathering information from patients receiving standard care. The study aims to support future research by identifying the best testing methods and monitoring tools for Wilson disease. During the study, participants will provide data and biological samples at regular intervals. Researchers will analyze this information to develop and validate diagnostic scores and treatment monitoring markers. The primary outcome is the creation of a comprehensive Wilson disease registry over five years, which will support future studies and improve patient care. The study is observational and involves ongoing data collection without altering participants' standard treatment.
CONDITIONS
Brief Title
Natural History of Wilson Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Known diagnosis of Wilson disease
- Able and willing to provide informed consent for adults
- Parental or guardian permission and child assent for participants under 18, as per local regulations
You will not qualify if you...
- Diagnosis of Wilson disease has been excluded
- Unwilling to provide informed consent or assent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants with Wilson disease are observed longitudinally to study the natural history, diagnostic parameters, and treatment monitoring over time.
Periodic visits depending on individual treatment and monitoring needs
Trial Site Locations
Total: 6 locations
1
Yale University
New Haven, Connecticut, United States, 06520
Actively Recruiting
2
Advent Health
Orlando, Florida, United States, 32803
Actively Recruiting
3
Baylor College of Medicine
Houston, Texas, United States, 77030
Actively Recruiting
4
Seattle Children's Hospital
Seattle, Washington, United States, 98105
Actively Recruiting
5
Universitätsklinikum Heidelberg
Heidelberg, Germany, 69120
Actively Recruiting
6
Royal Surrey Country Hospital
Guildford, Surrey, United Kingdom, GU2
Actively Recruiting
Research Team
R
Ricarda Tomlin
S
Sefa Keserci, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here